This company develops a next-generation biophysical assay platform designed to enhance early drug discovery processes. The platform provides high-quality data at scale, moving research beyond traditional blind screening methods. This enables a shift toward more precise, targeted molecular design in pharmaceutical research.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many human enzymes are considered "under-drugged," meaning there are few or no effective small-molecule drugs available to modulate their activity. This lack of chemical tools hinders basic research and limits therapeutic options for diseases linked to these enzymes. Identifying selective inhibitors or activators for these enzymes is challenging due to the lack of validated screening methods.
Solution
The company develops and applies high-throughput biochemical assays to discover small-molecule drugs that target under-drugged human enzymes. Their approach involves creating robust, sensitive assays that can screen large chemical libraries to identify compounds that selectively modulate the activity of specific enzymes. By focusing on enzymes with limited existing drug options, the company aims to accelerate the drug discovery process and expand the therapeutic landscape for neglected targets. The assays are designed to identify both inhibitors and activators, providing a comprehensive approach to modulating enzyme function.
Target Audience
The primary audience includes pharmaceutical companies, biotechnology firms, and academic research institutions seeking to discover novel drug candidates for under-drugged enzyme targets.
Features
- High-throughput screening platform for identifying small-molecule modulators of enzyme activity
- Biochemical assays optimized for under-drugged human enzymes
- Capability to screen large chemical libraries for selective inhibitors and activators
- Development of custom assays tailored to specific enzyme targets